Its purchases alarm some right-wing conspiracy theorists, but in fact its ammo buying has been declining for years
Eviction notices rain down on Woodland Park in East Palo Alto
Half-measures won’t help regional lenders weather the next crisis
The camera maker’s Small World in Motion competition highlights how microscopes can enhance science’s understanding of what lies beyond the capacity of the naked eye
The sports apparel company’s new SpeedForm Apollo running shoes were featured in the recent Captain America sequel
Cornell's Johnson Graduate School of Management revamps its curriculum to give students more time for interview prep
Michael Rea, founder of Rx Savings Solutions, says he can pare employers' spending on prescription medications for workers
Founders: Jeff Stein, John Finn, and John Schmid
VC Investment over the last four quarters: $35.16 million
Founded in 2004, the 35-employee biopharmaceutical company is working to develop antibacterial drugs to treat infections caused by resistant bacteria. Besides the VC investment, Stein says Trius has raised $32 million in government grants and contracts. As far as his perspective on the impact of the recession on his company, which expects less than $1 million in revenues in 2008, Stein says it will make the fundraising environment more challenging and may impact the partner environment as well.
Key to startup success: "Recruit top-tier executives. Focus on advancing your most valuable asset and seek alternative financing for earlier-stage programs."